| 品牌 | SCRSTANDARD | CAS | 155593-75-2 |
|---|---|---|---|
| 貨號 | SCMR-500102-1mg | 規(guī)格 | 1mg |
| 供貨周期 | 現貨 | 應用領域 | 醫(yī)療衛(wèi)生,環(huán)保,化工,生物產業(yè),制藥/生物制藥 |
精神障礙指的是大腦機能活動發(fā)生紊亂，導致認知、情感、行為和意志等精神活動不同程度障礙的總稱。常見的有情感性精神障礙、腦器質性精神障礙等。致病因素有多方面：先天遺傳、個性特征及體質因素、器質因素、社會性環(huán)境因素等。許多精神障礙患者有妄想、幻覺、錯覺、情感障礙、哭笑無常、自言自語、行為怪異、意志減退，絕大多數病人缺乏自知力，不承認自己有-病，不主動尋求醫(yī)生的幫助。常見的精神病有：精神分裂癥、躁狂抑郁性精神障礙、更年期精神障礙、偏執(zhí)性精神障礙及各種器質性病變伴發(fā)的精神障礙等。
喹-硫平，①用于各型精神分裂癥，不僅對精神分裂癥陽性癥狀有效，對陰性癥狀也有一定效果。②也可以減輕與精神分裂癥有關的情感癥狀如抑郁、焦慮及認知缺陷癥狀。
對本品過敏者禁用。
注意事項
治療精神障礙藥物內標
治療精神障礙藥物內標
| 貨號 | 中文名 | 英文名 |
| 1. 抗精神病藥 | ||
| 奮乃-靜 | ||
| SCMR-500102 | [2H4]-奮乃-靜 | Perphenazine-d4 (phenothiazine-1,3,7,9-d4) |
| SCSI-302636 | [2H6]-奮乃-靜 | [2H6]-Perphenazine |
| SCSI-302637 | [2H6]-奮乃-靜二馬來酸鹽 | [2H6]-Perphenazine dimaleate |
| SCCT-401217 | [2H8]-奮乃-靜二鹽-酸鹽 | Perphenazine D8 HCl |
| 氯丙-嗪 | ||
| SCMR-500147 | [2H6]-氯丙-嗪鹽酸鹽 | [2H6]- Chlorpromazine Hydrochloride |
| SCSI-402381 | [13C,2H3]-氯丙-嗪鹽酸鹽 | [13C,2H3]-Chlorpromazine Hydrochloride |
| SCMR-107597 | [2H6]-氯丙-嗪草酸鹽 | [2H6]-Chlorpromazine Oxalate |
| SCSI-524225 | [2H6]-7-羥基氯丙-嗪 | [2H6]-7-Hydroxy chlorpromazine |
| SCSI-510644 | [2H6]-7-羥基氯丙-嗪鹽酸鹽 | [2H6]- 7-Hydroxy Chlorpromazine Hydrochloride |
| 氟哌-啶醇 | ||
| SCMR-408276 | [2H4]-氟哌-啶醇 | [2H4]-Haloperidol |
| SCSI-541280 | [2H4]-氟哌-啶醇 | [2H4]-Haloperidol |
| SCSI-401735 | [2H4]-氟哌-啶醇還原型 | [2H4]-Reduced Haloperidol |
| SCSI-512024 | [13C6]-氟哌-啶醇還原型 | [13C6]-Haloperidol reduced form |
| 舒-必利 | ||
| SCMR-501035 | [2H3]-S-(-)-舒必-利 | [2H3]-S- (-)-Sulpiride |
| SCCT-401004 | [2H5]-舒必-利 | [2H5]-Sulpiride |
| 氨磺-必利 | ||
| SCSI-510914 | [2H5]-氨磺必-利 | [2H5]-Amisulpride |
| SCSI-402827 | [2H5]-氨磺-必利 N-氧化物 | [2H5]-Amisulpride N-Oxide |
| 氟非那嗪 | ||
| SCSI-511193 | [2H4]-氟非那嗪癸酯 | [2H4]-Fluphenazine decanoate |
| SCSI-510183 | [2H8]-氟非那嗪 | [2H8]-Fluphenazine |
| SCCT-401218 | [2H8]-氟苯那嗪二鹽-酸鹽 | [2H8]-Fluphenazine Dihydrochloride |
| 氯-氮平 | ||
| SCSI-513062 | [13C,2H3]-氯-氮平 | [13C,2H3]-Clozapine |
| SCSI-511554 | [2H3]-氯-氮平 | [2H3]-Clozapine |
| SCYJ-504098 | [2H4]-氯-氮平 | [2H4]-Clozapine |
| SCMR-501499 | [2H8]-氯-氮平 | [2H8]-Clozapine |
| SCBD-131730 | [2H8]-氯-氮平N-氧化物 | [2H8]-Clozapine N-Oxide |
| SCSI-301265 | [2H4]-N-去甲氯-氮平 | [2H4]-N-Desmethylclozapine |
| SCMR-410768 | [2H8]-N-去甲氯-氮平 | [2H8]-N-Desmethyl Clozapine |
| 奧-氮平 | ||
| SCSI-400201 | [2H3]-奧-氮平 | [2H3]-Olanzapine |
| SCSI-529150 | [2H4]-奧-氮平 | [2H4]-Olanzapine |
| SCMR-411327 | [2H8]-奧-氮平 | [2H8]-Olanzapine |
| SCSI-512896 | [13C,2H3]-奧-氮平 | [13C,2H3]-Olanzapine |
| SCCT-401204 | [2H8]-N-去甲基奧-氮平 | [2H8]-N-Demethyl Olanzapine |
| 利培-酮 | ||
| SCSI-324086 | [2H4]-利培-酮 | [2H4]-Risperidone |
| SCSI-527004 | [2H5]-利培-酮 | [2H5]-Risperidone |
| SCSI-503206 | [2H6]-利培-酮 | [2H6]-Risperidone |
| SCSI-512390 | [13C4]-利培-酮 | [13C4]-Risperidone |
| 帕潘-立酮 | ||
| SCSI-513244 | [2H4]-帕潘-立酮 | [2H4]-9-Hydroxyrisperidone |
| SCSI-511377 | [2H4]-(R)-帕潘-立酮 | [2H4]- (R)-9-Hydroxy Risperidone |
| SCSI-511375 | [2H4]-(S)-帕潘-立酮 | [2H4]- (S)-9-Hydroxy Risperidone |
| SCBD-112098 | [2H4]-帕潘-立酮棕櫚酸酯 | [2H4]-Paliperidone Palmitate |
| 喹-硫平 | ||
| SCSI-527031 | [2H4]-喹-硫平富馬酸鹽 | [2H4]-Quetiapine Fumarate |
| SCCT-401219 | [2H8]-喹-硫平富馬酸鹽 | [2H8]-Quetiapine Fumarate |
| SCYJ-505396 | [2H4]-喹-硫平半富馬酸鹽 | [2H4]-Quetiapine Hemifumarate |
| SCSI-521143 | [2H8]-喹-硫平半富馬酸鹽(哌-嗪-d8) | [2H8]-Quetiapine Hemifumarate (piperazine-d8) |
| SCSI-401738 | [2H8]-喹-硫平二聚體雜質 | [2H8]-Quetiapine Dimer Impurity |
| SCSI-401013 | [2H8]-喹-硫平亞砜 | [2H8]-Quetiapine Sulfoxide |
| SCSI-401739 | [2H8]-喹-硫平羥基雜質二鹽-酸鹽 | [2H8]-Quetiapine Hydroxy Impurity Dihydrochloride |
| SCSI-301254 | [2H4]-二羥-乙基-喹-硫平草酸鹽 | [2H4]-Deshydroxyethyl-quetiapine oxalate salt |
| SCSI-400812 | [2H8]-7-羥基喹-硫平 | [2H8]-7-Hydroxy Quetiapine |
| SCSI-400799 | [2H8]-7-芐氧基-N-[[2-(2-羥基)乙氧基]乙基]喹-硫平 | [2H8]-7-Benzyloxy-N-des[[2- (2-hydroxy)ethoxy]ethyl] Quetiapine |
| SCSI-400533 | [2H8]-N-脫[2-(2-羥基乙氧基)乙基]喹-硫平 | [2H8]-N-Des[2- (2-hydroxyethoxy)ethyl] Quetiapine |
| SCSI-512603 | [13C2,2H4]-富馬酸喹-硫平 | [13C2,2H4]-Quetiapine fumarate |
| SCSI-512391 | [13C4]-半富馬酸喹-硫平 | [13C4]-Quetiapine hemifumarate |
| SCSI-512399 | [13C4]-降喹-硫平二鹽-酸鹽 | [13C4]-Norquetiapine dihydrochloride salt |
| 阿立-哌唑 | ||
| SCSI-401366 | [丁基-2H8]-阿立-哌唑 | [butyl-2H8]-Aripiprazole |
| SCSI-529057 | [2H8]-脫氫阿立-哌唑 | [2H8]-Dehydro aripiprazole |
| SCCT-621567 | [2H8]-脫氫阿立-哌唑鹽酸鹽 | [2H8]-Dehydro Aripiprazole Hydrochloride |
| 五氟-利多 | ||
| SCSI-510284 | [2H7]-五氟-利多 | [2H7]-Penfluridol |
| 2. 抗焦慮藥 | ||
| 阿普-唑侖 | ||
| SCSI-527086 | [2H5]-4-羥基阿普-唑侖 | [2H5]-4-Hydroxyalprazolam |
| 坦度-螺酮 | ||
| SCSI-529218 | [2H6]-坦度-螺酮酸中間體 | [2H6]-Tandospirone Acid Metabolite |
| SCSI-529219 | [2H8]-坦度-螺酮檸檬酸 | [2H8]-Tandospirone Citrate |
| SCSI-529244 | [2H8]-外-羥基坦度-螺酮 | [2H8]-exo-Hydroxytandospirone |
| 丁螺-環(huán)酮 | ||
| SCSI-400568 | [2H8]-丁螺-環(huán)酮二鹽-酸鹽 | [2H8]-Buspirone Dihydrochloride |
| SCSI-402295 | [2H8]-5-羥基丁螺-環(huán)酮 | [2H8]-5-Hydroxy Buspirone |
| SCSI-401232 | [2H8]-6-羥基丁螺-環(huán)酮 | [2H8]-6-Hydroxy Buspirone |
| 3. 鎮(zhèn)靜-催-眠藥 | ||
| 佐匹-克隆 | ||
| SCCT-401249 | [2H8]-佐匹克-隆 | [2H8]-Zopiclone |
| 唑吡-坦 | ||
| SCSI-401229 | [2H6]-唑-吡坦6-羧酸 | [2H6]-Zolpidem 6-Carboxylic Acid |
| SCSI-401230 | [2H6]-唑-吡坦苯基-4-羧酸 | [2H6]-Zolpidem Phenyl-4-carboxylic Acid |
| 4. 抗抑郁 | ||
| 阿戈-美拉汀 | ||
| SCYJ-504935 | [2H3]-阿戈美-拉汀 | [2H3]-Agomelatine |
| SCSI-511312 | [2H4]-阿戈-美拉汀 | [2H4]-Agomelatine |
| SCCT-101397 | [2H6]-阿戈美-拉汀 | [2H6]-Agomelatine |
| SCYJ-503277 | [2H3]-3-羥基阿戈-美拉汀 | [2H3]-3-Hydroxy agomelatine |
| SCYJ-503278 | [2H3]-7-去甲基-阿戈-美拉汀 | [2H3]-7-Desmethyl-Agomelatine |
| 氯米-帕明 | ||
| SCYJ-505579 | [2H3]-氯米-帕明鹽酸鹽 | [2H3]-Clomipramine HCI |
| SCSI-510592 | [2H6]-氯米-帕明 | [2H6]-Clomipramine |
| SCSI-401114 | [2H6]-氯米-帕明鹽酸鹽 | [2H6]- Clomipramine Hydrochloride |
| SCSI-510591 | [2H6]-氯米-帕明草酸鹽 | [2H6]-Clomipramine oxalate |
| SCMR-350898 | N-去甲基氯米-帕明 | N-Desmethylclomipramine hydrochloride |
| SCSI-510470 | [2H6]-N-去甲基氯米-帕明 | [2H6]-N-Desmethylclomipramine |
| SCSI-510297 | [2H7]-N-去甲基氯米-帕明 | [2H7]-N-Desmethylclomipramine |
| SCSI-510296 | [2H7]-N-去甲基氯米-帕明鹽酸鹽 | [2H7]-N-Desmethylclomipramine, hydrochloride salt |
| SCSI-401117 | [2H3]-N-脫甲基氯米-帕明鹽酸鹽 | [2H3]- N-Desmethyl Clomipramine Hydrochloride |
| SCSI-511096 | [2H4]-N-二去甲基氯米-帕明鹽酸鹽 | [2H4]-N-Didesmethylclomipramine hydrochloride salt |
| 多-塞平 | ||
| SCSI-511532 | [2H3]-多-塞平鹽酸鹽 | [2H3]- Doxepin Hydrochloride |
| SCSI-510563 | [2H6]-多-塞平鹽酸鹽 | [2H6]-Doxepine hydrochloride |
| SCYJ-503329 | [2H3]-去甲多-塞平鹽酸鹽 | [2H3]-Nordoxepin HCl |
| SCSI-529097 | [2H4]-去甲多-塞平鹽酸鹽 | [2H4]-Nordoxepin HCl |
| SCSI-512900 | [13C,2H3]-去甲多-塞平鹽酸鹽 | [13C,2H3]-Nordoxepin hydrochloride |
| 西酞普蘭 | ||
| SCSI-543001 | [2H6]-西酞普蘭 | [2H6]-Citalopram |
| SCCT-400872 | [2H4]-氫溴酸西-酞普蘭 | [2H4]-Citalopram HBr |
| SCSI-510594 | [2H6]-西酞普蘭草酸鹽 | [2H6]- Citalopram Oxalate |
| SCSI-510595 | [2H6]-西酞普蘭鹽酸鹽 | [2H6]-Citalopram hydrochloride |
| SCSI-401144 | [2H6]-(S)-西酞普蘭草酸鹽 | [2H6]- (S)-Citalopram Oxalate |
| SCSI-511246 | [2H4]-去甲基西酞普蘭 | [2H4]-Desmethylcitalopram |
| SCSI-401190 | [2H3]-(±)-去甲基西酞普蘭鹽酸鹽 | [2H3]-- (±)-Demethyl Citalopram Hydrochloride |
| SCSI-403970 | [2H4]-(±)-脫甲基西酞普蘭氫溴酸鹽 | [2H4]- (±)-Desmethyl Citalopram Hydrobromide |
| SCSI-513047 | [13C,2H3]-去甲基西酞普蘭草酸鹽 | [13C,2H3]-Desmethylcitalopram oxalate |
| SCSI-511236 | [2H4]-二去甲基西酞普蘭 | [2H4]-Didesmethylcitalopram |
| SCSI-400780 | [2H6]-（±）-二去甲基西酞普蘭鹽酸鹽 | [2H6]- (±)-Didemethyl Citalopram Hydrochloride |
| SCSI-404128 | [2H6]-二去甲基西酞普蘭氫溴酸鹽 | [2H6]- Didemethyl Citalopram Hydrobromide |
| SCSI-511235 | [2H4]-二去甲基西酞普蘭草酸鹽 | [2H4]-Didesmethylcitalopram oxalate salt |
| SCSI-403803 | [2H4]-(S)-西酞普蘭草酸鹽 | [2H4]- (S)-Citalopram Oxalate |
| 氟伏沙明 | ||
| SCYJ-519096 | 馬來酸-氟伏沙明 | Fluvoxamine maleate |
| SCSI-511192 | [2H4]-氟伏沙明酸 | [2H4]-Fluvoxamine acid |
| SCSI-315096 | [2H3]-馬來酸-氟伏沙明 | [2H3]-Fluvoxamine Maleate |
| SCSI-522998 | [2H4]-馬來酸-氟伏沙明 | [2H4]-Fluvoxamine Maleate |
| SCSI-401129 | [2H3]-(E)-氟伏沙明馬來酸鹽 | [2H3]- (E)-Fluvoxamine Maleate |
| SCSI-404097 | [2H4]-(E)-氟伏沙明馬來酸鹽 | [2H4]- (E)-Fluvoxamine Maleate |
| 米-氮平 | ||
| SCSI-511465 | [2H3]-米-氮平 | [2H3]-Mirtazapine |
| SCYJ-505547 | [2H4]-米-氮平 | [2H4]-Mirtazapine |
| SCSI-511118 | [2H4]-米-氮平二鹽-酸鹽 | [2H4]-Mirtazapine dihydrochloride |
| SCSI-512932 | [13C,2H3]-米-氮平 | [13C,2H3]-Mirtazapine |
| SCSI-511245 | [2H4]-去甲基米-氮平 | 2H4]-Desmethylmirtazapine |
| SCSI-511244 | [2H4]-去甲基米-氮平二鹽-酸鹽 | [2H4]-Desmethylmirtazapine dihydrochloride |
| SCBD-109189 | [2H6]-去甲基米-氮平二鹽-酸鹽 | [2H6]- Desmethyl Mirtazapine Dihydrochloride |
| SCSI-404218 | [2H6]-脫甲基2N-亞硝基米-氮平 | [2H6]-Desmethyl 2N-Nitroso Mirtazapine |
| SCSI-512070 | [13C6]-去甲基米-氮平 | [13C6]-Desmethylmirtazapine |
| 舍曲林 | ||
| SCCT-400703 | [2H3]-舍曲林鹽酸鹽 | [2H3]- Sertraline Hydrochloride |
| SCSI-511864 | [13C6]-鹽酸舍-曲林 | [13C6]-Sertraline hydrochloride |
| SCSI-512843 | [13C,2H3]-舍曲林鹽酸鹽 | [13C,2H3]-Sertraline hydrochloride |
| SCSI-520995 | [2H3]-(±)-反式舍曲林鹽酸鹽 | [2H3]- (±)-trans Sertraline Hydrochloride |
| SCSI-522979 | [2H3]-(±)-順式-N-去甲基舍曲林鹽酸鹽 | [2H3]- (±)-cis-N-Desmethylsertraline HCl |
| SCSI-401851 | [2H4]-(±)-順式-N-脫甲基舍曲林鹽酸鹽 | [2H4]- (±)-cis-N-Desmethyl Sertraline Hydrochloride |
| SCSI-522980 | [2H3]-(±)-反式-N-去甲基舍曲林鹽酸鹽 | [2H3]- (±)-trans-N-Desmethylsertraline HCl |
| SCSI-511938 | [13C6]-N-去甲基舍曲林 | [13C6]-N-Desmethylsertraline |
| SCSI-511937 | [13C6]-N-去甲基舍曲林鹽酸鹽 | [13C6]-N-Desmethylsertraline hydrochloride |
| 氟-西汀 | ||
| SCSI-401593 | [2H5]-(R)-氟-西汀鹽酸鹽 | [2H5]- (R)-Fluoxetine Hydrochloride |
| SCSI-401594 | [2H5]-(S)-氟-西汀鹽酸鹽 | [2H5]- (S)-Fluoxetine Hydrochloride |
| SCSI-512036 | [13C6]-鹽酸氟-西汀 | [13C6]-Fluoxetine hydrochloride |
| SCSI-541414 | [2H5]-(±)-鹽酸氟-西汀 | [2H5]- (±)-Fluoxetine hydrochloride |
| SCSI-520755 | [2H4]-(±)-氟-西汀草酸鹽 | [2H4]- (±)-Fluoxetine Oxalate |
| SCSI-413423 | [2H5]-(±)-氟-西汀草酸鹽 | [2H5]- (±)-Fluoxetine Oxalate |
| SCSI-401595 | [2H5]-(R)-諾氟-西汀 | [2H5]- (R)-Norfluoxetine |
| SCSI-400637 | [2H5]-諾氟-西汀鹽酸鹽 | [2H5]-Norfluoxetine Hydrochloride |
| SCSI-510752 | [2H5]-諾氟-西汀草酸鹽 | [2H5]-Norfluoxetine oxalate salt, racemic mixture |
| 帕羅-西汀 | ||
| SCSI-311789 | [2H4]-帕羅-西汀 | [2H4]-Paroxetine |
| SCCT-400744 | [2H4]-(±)-帕羅-西汀鹽酸鹽 | [2H4]- (±)-Paroxetine Hydrochloride |
| SCSI-400247 | [2H4]-(±)-反式-帕羅-西汀鹽酸鹽 | [2H4]- (±)-trans-Paroxetine Hydrochloride |
| SCSI-510450 | [2H6]-帕羅-西汀草酸鹽 | [2H6]-Paroxetine oxalate |
| 伏氧西汀 | ||
| SCMR-414978 | [2H8]-伏氧西汀 | [2H8]-Vortioxetine |
| SCCT-400409 | [13C6]-沃替西汀氫溴酸 | [13C6]-Vortioxetine hydrobromide |
| 文拉-法辛 | ||
| SCSI-311783 | [2H4]-文拉-法辛 | [2H4]-Venlafaxine |
| SCSI-400133 | [2H6]-DL-文拉-法辛 | [2H6]-DL-Venlafaxine |
| SCCT-400528 | [2H10]-鹽酸文拉-法辛 | [2H10]-Venlafaxine hydrochloride |
| SCMR-350792 | O-去甲文拉-法辛 | O-Desmethyl venlafaxine |
| SCSI-311784 | O-去甲文拉-法辛-d4 | O-Desmethyl venlafaxine-d4 |
| SCCT-401064 | rac-O-去甲文拉-法辛-D6 | rac-O-Desmethyl Venlafaxine-d6 |
| SCSI-511705 | [2H10]-O-去甲文拉-法辛 | [2H10]-O-Desmethylvenlafaxine |
| SCSI-314820 | [2H6]-(R)-去甲基文拉-法辛 | (R)-Desmethyl Venlafaxine |
| SCCT-401042 | [2H6]-(S)-去甲基文拉-法辛 | (S)-Desmethyl Venlafaxine |
| SCSI-400827 | [2H3]-(±)-N-去甲文拉-法辛 | [2H3]- (±)-N-Desmethyl Venlafaxine |
| SCSI-400826 | [2H3]-(±)-N,O-二去甲基文拉-法辛 | [2H3]- (±)-N,O-Didesmethyl Venlafaxine |
| SCSI-523132 | [2H6]-(±)-去甲文拉-法辛琥珀酸水合物 | [N,N-dimethyl-2H6]- (±)-Desvenlafaxine Succinate Hydrate |
SCRSTANDARD屬于上海賽可銳旗下進口品牌，為科研工作者提供優(yōu)質產品和真誠服務。
SCRSTANDARD品牌，產品種類齊全，主要包括以下幾類：
◆藥物化合物及其穩(wěn)定同位素標記物 ◆氨基酸及其穩(wěn)定同位素標記物
◆糖類及其穩(wěn)定同位素標記物 ◆維生素及其穩(wěn)定同位素標記物
◆脂類及其穩(wěn)定同位素標記物 ◆肉堿及其穩(wěn)定同位素標記物
◆膽汁酸及其穩(wěn)定同位素標記物 ◆激素類固醇類及其穩(wěn)定同位素標記物
◆植物提取物及其穩(wěn)定同位素標記物 ◆聚合物及其穩(wěn)定同位素標記物（包括GPC分子量標品，PEG衍生物等）
◆環(huán)境檢測標物及其穩(wěn)定同位素標記物 ◆工業(yè)檢測標物及其穩(wěn)定同位素標記物
◆農殘獸殘檢測標物及其穩(wěn)定同位素標記物 ◆標準溶液及其穩(wěn)定同位素標記物（色度標液, AAS, ICP, ICP-MS, IC等標液）
◆食品檢測標物及其穩(wěn)定同位素標記物 ◆基質檢測標物及其穩(wěn)定同位素標記物
上一篇 : SCSI-400921抗腫瘤、抗癌藥系列
咨詢電話